Cerebral effects of carbamazepine capsules and Divitabs in psychiatric patients.
Loonen
A J
AJ
Doorschot
C H
CH
Van Bavel
L P
LP
Groot
B
B
De Blok
H J
HJ
Krijgsman
L J
LJ
Van Dongen
P H
PH
Jaspers
A A
AA
Vanbrabant
L C
LC
D000328:Adult; D001921:Brain / Q000187:drug effects*; D002214:Capsules; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D003072:Cognition Disorders / Q000139:chemically induced* / Q000175:diagnosis; D003692:Delayed-Action Preparations; D003866:Depressive Disorder / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests
D002214:Capsules; D003692:Delayed-Action Preparations; D002220:Carbamazepine